CD8 T Cell Mediated Immunity to Neurotropic MHV Infection

  • Cornelia C. Bergmann
  • Norman W. Marten
  • David R. Hinton
  • Beatriz Parra
  • Stephen A. Stohlman
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 494)


Neurological disease induced by neurotropic coronaviruses has received considerable attention not only as a model for virus induced demyelination, but also of immune regulation and viral persistence within the central nervous system (CNS). The neurotropic JHM strain (JHMV) of mouse hepatitis virus (MHV) produces an acute CNS infection characterized by encephalomyelitis and demyelination. Several strains and variants have been derived from the lethal, parental JHMV to better study the demyelinating process as a subacute disease resembling the human CNS disease, Multiple Sclerosis. A concise overview of historical aspects, derivation of neurotropic Coronavirus strains and variants, together with types of neurological disease and immune responses associated with these viruses is provided in the previous volume of this series (Perlman, 1998) and in several other recent reviews (Houtman and Fleming 1996, Lane and Buchmeier 1997, Stohlman et al 1999). Advances in molecular immunology techniques, combined with the use of selective exclusion of immune components, either using antibody (Ab) mediated depletion or genetic disruption, has resulted in significant progress in dissecting the interactions between virus, CNS cells, and immune responses and their role in demyelination. This chapter therefore focuses on advances of the past 3-4 years in elucidating interactions between CNS infection and immune responses leading to persistence. As MHV variants differ vastly in tropism, spread, clinical symptoms and mortality, this review focuses largely on a murine model of infection using the neuroattenuated 2.2v-l variant of JHMV (Fleming et al 1986). This mAb selected variant establishes a persistent infection associated with extensive, subacute, ongoing CNS demyelination in the absence of infectious virus. During acute infection this virus replicates primarily in microglia, astrocytes and oligodendrocytes. Although the immune response of immunocompetent hosts generally eliminates infectious virus within 14 days post infection (p.i.), survivors remain persistently infected as evidenced by the detection of viral RNA (vRNA). Despite suffering from varying degrees of encephalitis and paralysis during acute infection, mice generally recover from clinical symptoms and remain asymptomatic during viral CNS persistence.


Infected Mouse Cell Mediate Immunity Infectious Virus Central Nervous System Infection Viral Clearance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Ahmed, R., and Gray, D., 1996, Immunological memory and protective immunity: understanding their relation. Science 272:54–60.PubMedCrossRefGoogle Scholar
  2. Airman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M. M., 1996, Phenotypic analysis of antigenspecific T lymphocytes. Science 274:94–96.CrossRefGoogle Scholar
  3. Bergmann, C. C., Airman, J. D., Hinton, D. R., and Stohlman, S. A., 1999, Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the CNS. J. Immunol. 63:3379–3387.Google Scholar
  4. Castro, R. F., and Perlman, S., 1996, Differential antigen recognition by T cells from the spleen and central nervous system of coronavirus-infected mice. Virology 222:247–251.PubMedCrossRefGoogle Scholar
  5. Cserr, H. F. and Knopf, P. M., 1997, Cervical lymphatics, the blood brain barrier, and immunoreactivity of the brain. In Immunology of the Central Nervous System (R. W. Keane and W. F. Hickey, eds.) Oxford University Press, Oxford pp. 134–152.Google Scholar
  6. Doherty, P. C., Hou, S, and Tripp, R. A., 1994, CD8+ T-cell memory to viruses. Cur. Opin. Immunol. 6:545–552.CrossRefGoogle Scholar
  7. Fleming, J. O., Trousdale, M., Zactarim, F. E., Stohlman, S. A., and Weiner, L. P., 1986, Pathogenicity of antigenic variants of murine Coronavirus JHM selected with mAb. J. Virol. 58:869–875.PubMedGoogle Scholar
  8. Flynn, K. J., Belz, G. T., Altman J. D., Ahmed, R., Woodland, D. L., and Doherty P. C., 1998, Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683–691.PubMedCrossRefGoogle Scholar
  9. Hawke, S., Stevenson, P. G., Freeman, S. and Bangham C. R. M., 1998, Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J. Exp.Med. 187:1575–1582.PubMedCrossRefGoogle Scholar
  10. Hickey, W. F., Lassman, H., and Cross, A. H., 1997, Lymphocyte entry and the initiation of inflammation in the central nervous system. In Immunology of the Central Nervous System (R. W. Keane and W. F. Hickey, eds.) Oxford University Press, Oxford pp. 200–225.Google Scholar
  11. Homann, D., Tishon, A., Berger, D. P., Weigle, W. O., von Herrath, M. G., and Oldstone, M. B. A., 1998, Evidence of an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice. J. Virol. 72:9208–9216.PubMedGoogle Scholar
  12. Houtman, J. J., and Fleming, J. O., 1996, Pathogenesis of mouse hepatitis virus-induced demyelination. J. Neurovirol. 2:361–376.PubMedCrossRefGoogle Scholar
  13. Lane, T. E., Asensio, V. C., Yu, N., Paoletti, A. D., Campbell, I. L., and Buchmeier, M. J., 1998, Dynamic regulation of alpha-and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J. Immunol. 160:970–978.PubMedGoogle Scholar
  14. Lane, T. E., Liu, M. T., Chen, B. P., Asensio, V. C., Samawi, R. M., Paoletti, A. D., Campbell, I. L., Kunkel, S. L., Fox, H. S., and Buchmeier, M. J., 2000, A central role for CD4 T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 74:1415–1424.PubMedCrossRefGoogle Scholar
  15. Lane, T., and Buchmeier, M. J., 1997, Murine Coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends in Microbiology 1:9–14.CrossRefGoogle Scholar
  16. Lane, T. E., Paoletti, A. D., and Buchmeier M. J., 1997, Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine Coronavirus. J. Virol. 71:2202–2210.PubMedGoogle Scholar
  17. Lin, M. T., Stohlman, S. A., and Hinton, D. R., 1997, Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 71:383–391.PubMedGoogle Scholar
  18. Lin, M. T., Hinton, D. R., Marten, N. W., Bergmann, C. C., Stohlman, S. A., 1999, Antibody prevents virus reactivation within the central nervous system. J. Immunol. 162:7358–7368.PubMedGoogle Scholar
  19. Lipton, H. L., and Gilden, D. H., 1997, Viral Diseases of the Nervous System: Persistent Infections. In Viral Pathogenesis (N. Nathanson et al., eds) Lippencott-Raven Publishers, Philadelphia, pp. 855–869.Google Scholar
  20. Marten, N. W., Stohlman, S. A., Atkinson, R. D., Hinton, D. R., Fleming, J. O., and Bergmann, C. C., 2000a, Contributions of CD8+ T cells and viral spread to demyelinationg disease. J. Immunol. 164:4080–4088PubMedGoogle Scholar
  21. Marten, N. W., Stohlman, S. A., and Bergmann, C. C., 2000b, The role of viral persistence in retaining CD8+ T cells within the central nervous system. J. Virol. In press.Google Scholar
  22. Marten, N. W., Stohlman, S. A., Smith-Begolka, W., Miller, S. D., Dimacali, E., Yao, Q., Stohl, S., Goverman, J., and Bergmann C. C., 1999, Selection of CD8+ T cells with a highly focused specificity during viral persistence in the central nervous system. J. Immunol. 162:3905–3914.PubMedGoogle Scholar
  23. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. S., Slansky, J., and Ahmed, R., 1998, Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during virual infection. Immunity 8:177–187.PubMedCrossRefGoogle Scholar
  24. Parra, B., Hinton, D., Marten, N. W., Bergmann, C. C., Lin, M. T., Yang, C. S., Stohlman,. A., 1999 Gamma Interferon is required for viral clearance from central nervous system Oligodendroglia. J. Immunol. 162:1641–1647.PubMedGoogle Scholar
  25. Parra, B., Lin, M. T., Stohlman, S. A., and Bergmann, C. C., Atkinson, R., and Hinton, D. A., 2000, Fas-Fas Ligand Interactions do not contribute to the pathogenesis of mouse hepatitis virus in the presence of perform mediated cytolysis. J. Virol. 74:2447–2450.PubMedCrossRefGoogle Scholar
  26. Perlman, S. 1998. Pathogenesis of coronavirus-induced infections. Adv. Exp. Med. Biol. 440:503–513.PubMedCrossRefGoogle Scholar
  27. Pewe, L., Heard, S. B., Bergmann, C. C., Dailey, M. O., and Perlman, S., 1999, Selection of T cells escape mutants in mice infected with a neurotropic Coronavirus: Quantitative estimate of TCR Diversity in the infected CNS. J. Immunol. 163:6106–6113.PubMedGoogle Scholar
  28. Sedgwick, J. D., and Hickey, W. F., 1997, Antigen presentation in the central nervous system. In Immunology of the Central Nervous System (R. W. Keane and W. F. Hickey, eds.) Oxford University Press, Oxford, pp. 364–418.Google Scholar
  29. Stohlman, S. A., Bergmann, C. C., Lin, M. T., Cua, D. J., and Hinton, D., 1998, CTL effector function within the central nervous system requires CD4+ T cells. J. Immunol. 160:2896–2904.PubMedGoogle Scholar
  30. Stohlman, S. A., Bergmann, C. C., and Perlman, S., 1999, Persistent mouse hepatitis viral infections. In Persistent Viral Infections. (R. Ahmed and I. Chen, eds.) John Wiley and Sons, pp. 537–557.Google Scholar
  31. Stohlman, S. A., Bergmann, C. C., van der Veen, R., and Hinton, D., 1995, Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 69:684–694.PubMedGoogle Scholar
  32. Stohlman, S. A., Kyuwa, S., Polo, J. M., Brady, D., Lai, M..M. C., and Bergmann, C. C., 1993, Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J. Virol. 67:7050–7059.PubMedGoogle Scholar
  33. Williamson, J. S. P., and Stohlman, S. A., 1990, Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J. Virol. 64:4589–4592PubMedGoogle Scholar
  34. Williamson, J. S., Sykes, K. C., and Stohlman, S. A., 1991, Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 32; 199–207.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Cornelia C. Bergmann
    • 1
    • 2
  • Norman W. Marten
    • 3
  • David R. Hinton
    • 3
  • Beatriz Parra
    • 2
  • Stephen A. Stohlman
    • 1
    • 2
  1. 1.Departments of NeurologyPathology University of Southern California, Keck School of MedicineLos AngelesUSA
  2. 2.Molecular Microbiology and ImmunologyPathology University of Southern California, Keck School of MedicineLos AngelesUSA
  3. 3.Pathology University of Southern California, Keck School of MedicineLos AngelesUSA

Personalised recommendations